mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |